Skip to content

Clinical trials

Phase 2 Alzheimer Disease trials in Slovakia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Phase: Phase 2 Country / region: Slovakia Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20093
20101
20111
20131
20151
20161
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline3
Affiris AG2
AbbVie (prior sponsor, Abbott)1
Axon Neuroscience SE1
Hoffmann-La Roche1
Institut de Recherches Internationales Servier1
Intra-Cellular Therapies, Inc.1
MapLight Therapeutics1
Targacept Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease12
Dementia3
Brain Diseases2
Mental Disorders2
Nervous System Diseases2
Neurodegenerative Diseases2
Psychotic Disorders2
Tauopathies2
Central Nervous System Diseases1
Frontotemporal Dementia1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.